🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Exploring Parameters of Driving Simulation in Relation to Drug Holidays in ADHD Patients

RecruitingNAAges 10 Years - anyAllStefan Lakämper
NCT06910605 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Attention deficit hyperactivity disorder (ADHD) or syndrome (ADHS) is a symptomatically defined condition that - if untreated - is linked to a significantly increased risk of traffic accidents. In a recent umbrella review, where data from reviews and meta-analyses on 21.142.129 adults was assessed, a pooled prevalence of 3.1% of ADHD in adults was estimated. Considering that globally around 1.35 million people lose their lives and more than 50 million are suffering from injuries or disabilities due to road accidents, the fraction of car accidents caused by ADHD as a risk factor is considerable and needs to be addressed. This risk is largely presumed to be caused by an elevated level of inattentiveness in affected persons. Compounds of different groups, which can be classified in stimulants - formulations of methylphenidate and amphetamine - and non-stimulants - atomoxetin, guanfacine an

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria: * adult drivers * ADHD-diagnosed, established ADHD-treatment only with stimulants * known history of drug holidays based on own decision, * at impaired eyesight with more than +/- 5 diopter or astigmatism * contact lenses are required (for eye tracking) Exclusion criteria: * sensibility to motion sickness (kinetosis, dizziness etc. in 5 min screening drive) * non-stimulant-treatment * inability to understand the study procedure for linguistic or cognitive reasons * professional drivers (if working during the study period) * for women: pregnancy
💊

What it tests

  • "drug holidays" (D)
📍

Where

1 site
Division of Traffic Medicine, Institute of Forensic Medicine, University of Zurich,
Zurich, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy